MedPath

GI Tolerance and Acceptability of a New Thickener

Not Applicable
Withdrawn
Conditions
Gastro-intestinal Tolerance
Interventions
Other: Experimental Thickener
Registration Number
NCT04104815
Lead Sponsor
Abbott Nutrition
Brief Summary

The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Subject has voluntarily signed and dated an ICF approved by an IRB/IEC, and provided applicable privacy authorization prior to any participation in the study.
  • Subject is diagnosed with dysphagia.
  • Subject is under the care of a Speech and Language Therapist and is currently using a thickener.
  • Subject currently has normal GI function.
  • Subject is interested in participating in the study, willing to comply with the study protocol and product.
  • Subject who is able to consent and is able to evaluate the product.
Exclusion Criteria
  • Subject has a normal swallow.
  • Subject at high risk of aspiration with oral fluids requiring nil by mouth and enteral tube feeding.
  • Subject has impaired renal function.
  • Subject has liver failure, decompensated chronic liver disease, active hepatitis B or C receiving treatment, or hepatic encephalopathy.
  • Subject has severe dementia or unable to communicate or consent or delirium, eating disorder, history of significant neurological or psychiatric disorder affecting abilities to answer questions, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures.
  • Participant is known to be allergic or intolerant to any ingredient found in the study product.
  • Participation in another study that has not been approved as a concomitant study.
  • Subject has a clinical condition that is contraindicated with this product such as hepatic and renal disease.
  • Subject has a clinical condition which may interfere with gastrointestinal tolerance.
  • Subject is pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental ThickenerExperimental ThickenerPowder thickener
Primary Outcome Measures
NameTimeMethod
HCP Product Satisfaction QuestionnaireStudy Day 7

5 Questions; 3 of the questions utilize a 5 point scale in the positive direction; 2 of the questions are closed categories yes or no.

Product ComplianceStudy Day 1 to Study Day 7

Patient thickened fluids consumption records

Bristol Stool ScaleStudy Day 1 to Study Day 7

The Bristol Stool Scale is used to describe the consistency of stools. Numbers 1-7 are assigned to stools based on descriptions on the scale from hard to liquid.

Palatability of Study ProductStudy Day 1 and Study Day 7

A 5 point scale in the positive direction

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath